{"id":16676,"date":"2025-08-06T19:49:32","date_gmt":"2025-08-06T14:19:32","guid":{"rendered":"http:\/\/43.205.138.160\/?post_type=media-review&#038;p=16676"},"modified":"2025-08-06T19:49:32","modified_gmt":"2025-08-06T14:19:32","slug":"16676","status":"publish","type":"media-review","link":"https:\/\/signalz.pro\/media-review\/16676\/","content":{"rendered":"<p><a href=\"http:\/\/43.205.138.160\/wp-content\/uploads\/2025\/08\/LAURUSLABS_06082025192722.pdf\">LAURUSLABS_06082025192722<\/a><\/p>\n<p>Founded in 2005, Laurus Labs is a research-driven pharmaceutical and biotechnology company having a global leadership position in select Active Pharmaceutical Ingredients (APIs) including anti-retroviral, oncology drugs (incl High Potent APIs), Cardiovascular, and Gastro therapeutics. They also offer integrated CMO and CDMO services to Global Innovators from Clinical phase drug development to<br \/>\ncommercial manufacturing.<\/p>\n<p>The company had shown rise on healthy volumes and on the back of good results. As shown in chart, stock is correcting the earlier rise with declining volumes and testing 20EMA which is likely to act as strong support level. Sustaining the earlier momentum with pick up in volumes again is likely to result in faster retracement of the fall. Comany registered strong quarterly results in Q1FY26 with pharma sector showing relative strength vis-a-vis broader market over last 1 month. Overall, company has strong fundamental (Q1FY26 results), sector tailwinds (CDMO player) with short term uncertainities due to tariff related news flows and chart looks strong giving high probability to sustaining momentum in short term.<\/p>\n","protected":false},"comment_status":"closed","ping_status":"closed","template":"","media-category":[9],"media-subscription":[],"call-tags":[],"class_list":["post-16676","media-review","type-media-review","status-publish","hentry","media-category-stock-exchange"],"acf":[],"_links":{"self":[{"href":"https:\/\/signalz.pro\/api\/wp\/v2\/media-review\/16676","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/signalz.pro\/api\/wp\/v2\/media-review"}],"about":[{"href":"https:\/\/signalz.pro\/api\/wp\/v2\/types\/media-review"}],"replies":[{"embeddable":true,"href":"https:\/\/signalz.pro\/api\/wp\/v2\/comments?post=16676"}],"version-history":[{"count":1,"href":"https:\/\/signalz.pro\/api\/wp\/v2\/media-review\/16676\/revisions"}],"predecessor-version":[{"id":16678,"href":"https:\/\/signalz.pro\/api\/wp\/v2\/media-review\/16676\/revisions\/16678"}],"wp:attachment":[{"href":"https:\/\/signalz.pro\/api\/wp\/v2\/media?parent=16676"}],"wp:term":[{"taxonomy":"media-category","embeddable":true,"href":"https:\/\/signalz.pro\/api\/wp\/v2\/media-category?post=16676"},{"taxonomy":"media-subscription","embeddable":true,"href":"https:\/\/signalz.pro\/api\/wp\/v2\/media-subscription?post=16676"},{"taxonomy":"call-tags","embeddable":true,"href":"https:\/\/signalz.pro\/api\/wp\/v2\/call-tags?post=16676"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}